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Abstract White matter hyperintensities (WMH) have
been associated with mood disorders in psychiatric
patients. In the present study, we aimed to assess whether
WMHs are associated with depressive symptoms and dif-
ferent sensitivity of the behavioral inhibition (BIS), and
activation (BAS) systems in patients with chronic head-
ache. Participants were 85 adult outpatients (16 men and 69
women) with a diagnosis of chronic headache. All of the
patients underwent brain magnetic resonance imaging
(MRI) and were administered the BIS/BAS scales and the
Center for Epidemiologic Studies Depression Scale. Above
40 % of patients had periventricular WMHs (PWMHs) and
almost 98 % had deep WMHs (DWMHs). Patients with
PWMHs reported fewer depressive symptoms than patients
without PWMHs. Patients with more severe DWMHs
(compared with patients with mild or without DWMH
lesions) were older and reported lower scores on the drive
dimension of the BIS/BAS scales. In multivariate analyses,
patients with PWMHs were 1.06 times more likely to
report fewer depressive symptoms than patients without
PWMHs. WMH lesions in patients with chronic headache
were associated with less depression severity.
Keywords PWMHs  DWMHs  Chronic headache 
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Introduction
White matter hyperintensities (WMHs) appear as hyper-
intense signals on T2-weighted magnetic resonance images
(MRI) and represent ependymal loss and differing degrees
of myelination in the brain [1, 2]. WMHs, depending on the
localization, are commonly classified as periventricular
white matter hyperintensities (PWMHs) and deep white
matter hyperintensities (DWMHs). WMHs have been
reported to be commonly associated with older age and
cardiovascular risk factors such as hypertension and dia-
betes [3–5]. Degenerative changes in brain white matter
have been reported to be associated with mood disorders
and suicidal behavior both in children and young adults
[6–13]; however, they seem not to be specific to first epi-
sode psychotic disorders [14]. Taylor and colleagues
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hypothesized that patients with WMHs may be at a higher
risk for suicide and developing mood disorders due to a
possible disruption of neuroanatomic pathways [15]. Mood
regulation depends on the complex extensive connections
between the prefrontal cortex, amygdala–hippocampus
complex, thalamus and basal ganglia [16].
Studies in both clinical and community-based settings
have demonstrated the association between migraine and
a number of specific psychiatric disorders, particularly
major affective disorders [17–23]. Previous researchers
have hypothesized that the relation between migraine and
psychiatric disorder may be bi-directional given that
migraine patients have a more than threefold risk of
developing depression and the presence of depression is
also associated with a greater risk of developing a
migraine [21, 24].
Since the 1990s, brain MRI studies have investigated
the presence of focal hyperintense abnormalities in
patients with migraine [25]. Chronic migraine has been
associated with the presence of white matter hyperinten-
sities and migraine attack frequency, and attack history
may be considered as a contributor of brain abnormali-
ties in migraineurs [25]. In a sample of 28 patients
with migraine, using high-resolution T1- and diffusion-
weighted MRI and optimized voxel-based morphometry
to localize gray and white matter density, Schmitz et al.
[26] found that regions of brain abnormalities in migrai-
neurs were mainly located in the frontal lobes, brainstem,
and the cerebellum, and both attack frequency and disease
duration predicted brain damage in migraine patients. To
date, although the cause of migraine, particularly with
aura, is commonly recognized as ischemic, which is
consistent with its association with vascular risk factors
[25], the natural history of white matter abnormalities in
migraine patients is not completely understood. The
relation between increased volume of white matter hy-
perintensities and a history of severe headache is also a
matter of debate.
The structures and functions of a major motivational
system, the Behavioral Inhibition System (BIS), have been
described by Gray [27] in 1994. It has been suggested that
the BIS modulates behavioral inhibition, anxiety, attention,
and arousal towards signals of fear stimuli and punishment
[28, 29]. A strong BIS is indicative of anxiety and inhibi-
tion even if few fear stimuli are present, whereas a weak
BIS may not contribute to anxiety and inhibition even
when severe stimuli occur. Gray [27, 28] also described the
behavioral activation system (BAS) as a regulatory system
measuring positive affect and approach behavior towards
signals of reward. BAS activity may trigger positive affect
and increase the likelihood of incentive acquisition.
Refractoriness to incentives, low positive affect, and an
absence of environmental engagement may be associated
with a weak BAS [30].
As suggested by Gray [27, 28], the BIS may be con-
sidered an anxiety system and its activity may be investi-
gated in several psychiatric conditions [31]. The BIS scale
[32] includes seven items and assesses the tendency to
respond with negative affect, anxiety, or fear in response to
threatening events. The BAS scales [32] describe the ten-
dency to respond with positive affect and motivation when
faced with incentives or rewards. To our knowledge, no
studies have investigated the sensitivity of the BIS and
activation of the BAS concurrently with self-reported
depression among patients with WMHs and chronic
migraine.
In the present study, we aimed to assess whether WMHs
are associated with self-reported depressive symptoms and
different sensitivity of the BIS and BAS systems in patients
with chronic headache.
Methods
Participants
Participants were 85 adult outpatients (16 men and 69
women) admitted at the Regional Referral Headache
Centre, Department of Medical and Molecular Sciences,
Sapienza University of Rome, Italy, between June 2010
and June 2011. Inclusion criteria were 18 years of age or
older and a diagnosis of primary headache. Exclusion cri-
teria included the presence of any psychiatric disorders or
any condition affecting the ability of the patient to com-
plete the assessment, including the denial of informed
consent. The mean age of the sample was 50.13 ± 12.83
years (min/max 20/88 years). Table 1 summarizes the
headache diagnoses as per the international classification of
headache disorder (ICHD-II, ICHD-IIR).
All the patients voluntarily participated in the study and
provided written informed consent. The design of the study
was approved by the Hospital’s Ethics Committee.
Measures: clinical assessment
All the patients were administered the BIS/BAS scales and
the Center for Epidemiologic Studies Depression Scale
(CES-D).
BIS/BAS scales
The BIS scale [32] includes seven items and measures the
tendency to respond with negative affect, anxiety, or fear in
response to threatening events. An example of an item on
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the BIS is ‘‘If I think something unpleasant is going to
happen I usually get pretty ‘worked up’.’’ The BAS scales
[32] describe the tendencies to respond with positive affect
and motivation when faced with incentives or rewards. The
BAS includes three distinct subscales: reward respon-
siveness, drive, and fun seeking. Individuals scoring high
on the drive subscale are strongly motivated towards
specific goals. The tendency to respond with elevated
energy and positive affect when desired events are
experienced was measured by the reward responsiveness
scale. The fun-seeking subscale assessed the impulsive
behavioral desire of fun conditions. Adequate psycho-
metric properties (internal consistency, factor structure,
test–retest reliability) of the BIS/BAS scales have been
demonstrated [32–34]. Normative data were derived by a
major community sample [34].
CES-D scale
The CES-D scale is a short self-report scale designed to
measure current level of depressive symptomatology in the
general population, with an emphasis on the affective
component. The 20 items were selected from previously
validated depression scales. Participants were asked to rate
each item on a scale from 0 (rarely or none of the time: less
than 1 day) to 3 (most or all of the time 5–7 days) on the
basis of how often they have felt that way during the
previous week. The validity of the scale as a screening tool
for depression has been documented in several populations
[35–42]. In our sample, the Cronbach alpha for the CES-D
was 0.86.
Magnetic resonance image acquisition and rating
of white matter hyperintensities
Brain MRIs were performed using a Siemens Sonata
equipment, Erlangen, Germany (1.5 T). FLAIR scan
sequence was used for WMH measurement (ax: TR 10000;
TE 125; thickness 5 mm; matrix 144 9 256). Proton den-
sity and T2-weighted images were obtained (PD and T2 ax:
TR 2870; TE 13/107; thickness 5 mm; matrix 147 9 256)
in the axial and the coronal planes. Axial and sagittal
T1-weighted images were also obtained (T1 ax: TR 647;
TE 17; thickness 5 mm; matrix 128 9 192 T1 sag: TR
552; TE 17; thickness 5 mm; matrix 231 9 192). The
presence of WMH was assessed by a neuroradiologist blind
to all clinical information, using the modified Fazekas four-
point rating scale which describes MRI hyperintensities on
an ascending scale of intensity and frequency [43]. A
second neuroradiologist, blind to all clinical information
and previous ratings, reviewed all MRI films. The mean k
value for interrater reliability for both PWMHs and
DWMHs was 0.90. DWMHs and PWMHs as assessed by
the Fazekas modified scale are summarized in Table 2.
Statistical analysis
A series of t tests and one-way Fisher exact tests were used
to assess differences between groups. All the variables
significant at the bivariate analyses were inserted as inde-
pendent variables in a generalized linear model with a
robust estimator. Groups were inserted as criterion. Asso-
ciations between variables are reported as odds ratios (OR).
All of the analyses were performed with the statistical
package for social sciences SPSS 19.0 for Windows.
Results
Above 40 % of patients had PWMHs and almost 98 % had
DWMHs (see Table 2). Due to the low number of partic-
ipants included in some categories, we collapsed levels of
severity of white matter hyperintensity into two classes:
(1) periventricular lesions were categorized in absent/
present; and (2) deep lesions assessed as 0 and 1 at the
Fazekas were collapsed together while levels 2 and 3 were
combined.
Patients with PWMHs differed from those without
periventricular lesions on depression severity (t77.76 =
2.30; P \ 0.05) (Table 3). Patients with PWMHs had
lower CES-D scores (13.79 ± 7.51 vs. 18.19 ± 9.68) than
patients without PWMHs. Groups did not differ in age
(P = 0.37), sex (P = 0.17), or for scores on the BIS/BAS
scales.
Table 1 Diagnoses in the 85 study subjects (ICHD-II, ICHD-IIR)
Frequencya %
Chronic migraine 69 81.1
Migraine without aura 12 14
Migraine with aura 7 8.2
Episodic tension-type headache 4 4.7
Chronic tension-type headache 3 3.5
a Some patients presented multiple diagnoses
Table 2 DWMHs and PWMHs as assessed by the Fazekas modified
scale
PWMHs DWMHs
0 57.6 2.4
1 30.6 56.5
2 8.2 34.1
3 3.5 7.1
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Groups with different severity of DWMH lesions dif-
fered in age (t83 = -2.34; P \ 0.05) and on the mean
scores of the drive dimension of the BIS/BAS scales
(t83 = 1.99; P \ 0.05). Specifically, patients with more
severe DWMHs were older (53.89 ± 13.26 vs. 47.40 ±
11.91) and reported lower scores on the drive dimension
(9.97 ± 2.86 vs. 11.14 ± 2.52) than patients with mild or
without any deep lesion.
The variables found to be significant at the bivariate
level were inserted as independent variables in two gen-
eralized linear models with groups as dependent variables
(see Table 4, 5). The models fit the data well (PWMH:
Likelihood ratio v1
2 = 5.83; P \ 0.05; DWMH: Likelihood
ratio v2
2 = 8.24; P \ 0.05). Patients with PWMHs were
1.06 times more likely to have lower CES-D scores
(P \ 0.05) than patients without PWMHs. Patients with
more severe DWMHs were 1.04 times more likely to be
older (P \ 0.05) than patients with mild or without any
DWMH lesions.
Discussion
Our aim was to assess whether WMHs were associated
with depressive symptoms and sensitivity of the BIS and
BAS systems in patients with chronic headache. Our
findings suggest that differences in brain lesions are asso-
ciated with differences in age and self-reported depression
severity as measured by the CES-D.
Specifically, in multivariate analyses, individuals with
PWMHs were more likely to report fewer depressive
symptoms as compared with patients without PWMHs.
These findings contradict our previous results regarding the
association between white matter abnormalities and both
unipolar and bipolar depression [8, 11, 14]. However, in
our previous samples, we investigated patients with spe-
cific psychiatric conditions such as unipolar and bipolar
disorders, whereas the current sample includes only indi-
viduals with chronic migraine without any evidence of
comorbid psychiatric disorders. This may suggest that the
association between WMHs and higher levels of depression
is specific to particular subgroups of patients who have a
psychiatric disorder [11, 12, 14], and it may not be a factor
among inpatients with medical conditions.
Whether the presence of WMHs predicts a poor prog-
nosis in specific at-risk subgroups of patients has not been
clearly established. Taylor et al. [44] found a relation
between the progression and severity of WMHs and neg-
ative long-term outcomes in depressed patients. Prefrontal
WMHs have been associated with cognitive dysfunctions
in depressed older patients, poor or delayed antidepressant
response [45], and poor treatment outcomes were associ-
ated with subcortical and basal ganglia, but not periven-
tricular hyperintensities [46]. In contrast, there have been
studies which reported no differences in treatment response
and functional outcomes between elderly patients with and
without WMHs [47, 48].
In our sample, those patients with more severe DWMHs
differed from patients with mild or no DWMH lesions, as
they were more likely to be older. Previous studies have
strongly suggested that patients with migraine, particularly
those diagnosed as having migraine with aura and at least
12 migraine episodes per year [49–51], are at an increased
risk (with an odds ratio of 3.9) for subclinical brain infarct-
like lesions, even after controlling for the most common
cardiovascular risk factors and a history of cardiovascular
diseases [52]. Unfortunately, we only examined the effect
of age and did not consider whether patients with more
pronounced cardiovascular risk factors were more likely to
have DWMHs.
Although DWMHs have been suggested to have mainly
a vascular origin, recent studies have reported that these
brain lesions may reverse over time raising questions about
their hypothetic ischemic origin [53, 54]. It has been
demonstrated that frequent migraine attacks may be asso-
ciated with increased iron concentration/accumulation in
deep nuclei which is involved in central pain processing.
These findings suggest that iron accumulation might have a
Table 3 Differences between groups
PWMHs DWMHs
Absence of
PWMHs
Presence of
PWMHs
Test P No DWMHs or
mild lesions
Moderate to severe
DWMHs lesions
Test P
Men 14.3 % 25.0 % \0.17 20.0 % 17.1 % \0.48
Age 49.02 ± 12.76 51.58 ± 12.96 t83 = -0.90 \0.37 47.40 ± 11.91 53.89 ± 13.26 t83 = -2.34 \0.05
CES-D 18.19 ± 9.68 13.79 ± 7.51 t77.76 = 2.30 \0.05 15.69 ± 8.35 17.47 ± 10.13 t83 = -0.86 \0.39
CES-D C 16 52.1 % 36.4 % \0.12 44.9 % 46.9 % \0.52
Drive 10.49 ± 2.60 10.89 ± 2.89 t83 = -0.67 \0.51 11.14 ± 2.52 9.97 ± 2.86 t83 = 1.99 \0.05
Fun seeking 10.16 ± 2.50 10.19 ± 2.62 t83 = -0.06 \0.96 10.44 ± 2.45 9.80 ± 2.63 t83 = 1.15 \0.25
Reward responsiveness 16.76 ± 2.43 16.97 ± 2.25 t83 = -0.42 \0.68 17.24 ± 2.11 16.29 ± 2.57 t83 = 1.88 \0.06
BIS 22.16 ± 3.41 22.53 ± 3.20 t83 = -0.50 \0.62 22.34 ± 3.09 22.29 ± 3.64 t83 = 0.07 \0.94
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possible role in determining chronic migraine [49]. Other
hypotheses have been proposed to explain the existence of
white matter abnormalities in migraineurs although
definitive conclusions are still not established. It has been
suggested that recurrent migraine attacks may affect
vulnerable deep tissues penetrating arteries and contrib-
uting to local critical hypoperfusion leading to minor
brain injury observed as white matter abnormalities. Other
proposed mechanisms have been suggested including
atherosclerotic insults associated with the presence of
cardiovascular risk factors [55, 56], endothelial dysfunc-
tion (e.g., both endothelial activation and impaired vas-
cular reactivity) [57–59], genetic risk factors which are
common in migraine and stroke [60], drugs commonly
used to treat headache, having vasoconstrictor activity
[61], and cardiac dysfunctions such as patent foramen
ovale. In addition, irrespective of whether endothelial
dysfunction is linked to platelet aggregation, recurrent
endothelial insults may lead to microvascular brain
damage contributing to white matter lesions [62].
The present study must be considered in the light of the
following limitations. The small sample size limits the
generalizability of the current findings. In addition, our
MRI study was limited by low spatial resolution and per-
formed using only a 1.5 T MRI scanner. Studies using a 3 T
MRI scanner having a higher resolution are able to detect a
higher number and more precise extents of WMHs. An
analysis quantifying total white matter lesion volume
would strengthen the findings. Diffusion tensor imaging
techniques may be more sensitive in detecting white matter
abnormalities in association with mood disorders.
Recently, some authors [63] have demonstrated ‘‘occult’’
brain damage in migraine patients using diffusion-weigh-
ted MRI, particularly tractography.
Furthermore, the Fazekas modified rating scale, which
was used to measure the frequency and intensity of white
matter lesions, is a quantitative lesion assessment method
that may be limited since it is a visual rating scale less
objective than many volumetric methods available. Also,
we have not systematically assessed clinical disease course,
age, gender, comorbidities, or history of substance abuse
and dependence in the individuals recruited. In addition,
some limitations regarding the utilization of the CES-D
must be mentioned. Lack of consistency in some item
responses in the measurement of depression suggests that
response patterns may be affected by unique conceptual-
izations of depression among different ethnic groups [64].
Although the stability and applicability of the CES-D Scale
with various ethnic groups have been widely assessed, few
studies have addressed the cross-contextual generalizability
of the CES-D Scale.
Conclusion
Overall, patients with chronic headache having PWMHs
were more likely to have lower self-reported depression
than those without PWMHs, and patients with more severe
DWMHs were more likely to be older than those with less
severe DWMHs. Further studies are needed to investigate
the relation between progression of migraine and onset of
new white matter lesions while considering the possible
association between migraine attack rate and progression
of lesion impairment [25], as well as the link between
white matter lesions, major affective disorders, and
migraine attacks over time. Also, functional impairment
related to the presence of self-reported depression in
patients with chronic migraine should be considered in
Table 4 Generalized linear model: criterion PWMHs
Parameter B Std. error 95 % Wald confidence interval Hypothesis test 95 % CI
Lower Upper Wald Chi-square df Sig. OR Lower Upper
CES-D -0.07 0.03 -0.13 -0.01 4.66 1 0.05 0.94 0.88 0.99
Model fit: Likelihood ratio v1
2 = 5.83; P \ 0.05; AIC = 63.65; AICC = 63.81; Pearson v31
2 = 32.58; Value/g dl = 1.05
Table 5 Generalized linear model: criterion DWMHs
Parameter B Std. error 95 % Wald confidence interval Hypothesis test 95 % CI
Lower Upper Wald Chi-square df Sig. OR Lower Upper
Drive -0.16 0.09 -0.33 0.02 3.15 1 0.08 0.86 0.72 1.02
Age 0.04 0.02 0.01 0.08 5.23 1 0.05 1.04 1.01 1.08
Model fit: Likelihood ratio v2
2 = 8.24; P = 0.05; AIC = 109.02; AICC = 109.33; Pearson v77
2 = 81.15; Value/g dl = 1.05
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terms of long-term cognitive changes. Importantly, differ-
ent mechanisms may be considered in the emergence of
WMHs and it is possible that WMHs may represent only
the ‘tip of the iceberg’ in terms of structural white matter
lesions.
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